171 related articles for article (PubMed ID: 34651207)
21. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
[TBL] [Abstract][Full Text] [Related]
23. Clinical, Immunological, and Molecular Findings of Patients with p47
Kulkarni M; Desai M; Gupta M; Dalvi A; Taur P; Terrance A; Bhat S; Manglani M; Raj R; Shah I; Madkaikar M
J Clin Immunol; 2016 Nov; 36(8):774-784. PubMed ID: 27699571
[TBL] [Abstract][Full Text] [Related]
24. Transient association of the nicotinamide adenine dinucleotide phosphate oxidase subunits p47phox and p67phox with phagosomes in neutrophils from patients with X-linked chronic granulomatous disease.
Allen LA; DeLeo FR; Gallois A; Toyoshima S; Suzuki K; Nauseef WM
Blood; 1999 May; 93(10):3521-30. PubMed ID: 10233905
[TBL] [Abstract][Full Text] [Related]
25. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.
Bakri FG; Martel C; Khuri-Bulos N; Mahafzah A; El-Khateeb MS; Al-Wahadneh AM; Hayajneh WA; Hamamy HA; Maquet E; Molin M; Stasia MJ
J Clin Immunol; 2009 Mar; 29(2):215-30. PubMed ID: 18773283
[TBL] [Abstract][Full Text] [Related]
26. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.
Beaumel S; Verbrugge L; Fieschi F; Stasia MJ
Clin Exp Immunol; 2023 Apr; 212(2):156-165. PubMed ID: 36827093
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.
Al-Zadjali S; Al-Tamemi S; Elnour I; AlKindi S; Lapoumeroulie C; Al-Maamari S; Pathare A; Dennison D; Krishnamoorthy R
Clin Genet; 2015 Feb; 87(2):185-9. PubMed ID: 24446915
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations in unrelated Vietnamese patients with chronic granulomatous disease.
Binh NT; Lien NTK; Anh NTV; Mai NTP; Ha NTV; Ha DT; Tung NV; Hoang NH
Clin Chim Acta; 2022 Aug; 533():114-121. PubMed ID: 35728702
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china.
Xu H; Tian W; Li SJ; Zhang LY; Liu W; Zhao Y; Zhang ZY; Tang XM; Wang M; Wu DQ; Shi JS; Ding Y; Zhao XD; Yang XQ; Jiang LP
J Clin Immunol; 2014 Aug; 34(6):633-41. PubMed ID: 24943880
[TBL] [Abstract][Full Text] [Related]
32. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
33. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
Baba LA; Ailal F; El Hafidi N; Hubeau M; Jabot-Hanin F; Benajiba N; Aadam Z; Conti F; Deswarte C; Jeddane L; Aglaguel A; El Maataoui O; Tissent A; Mahraoui C; Najib J; Martinez-Barricarte R; Abel L; Habti N; Saile R; Casanova JL; Bustamante J; Salih Alj H; Bousfiha AA
J Clin Immunol; 2014 May; 34(4):452-8. PubMed ID: 24596025
[TBL] [Abstract][Full Text] [Related]
34. Chronic Granulomatous Disease.
Roos D
Methods Mol Biol; 2019; 1982():531-542. PubMed ID: 31172494
[TBL] [Abstract][Full Text] [Related]
35. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
Martel C; Mollin M; Beaumel S; Brion JP; Coutton C; Satre V; Vieville G; Callanan M; Lefebvre C; Salmon A; Pagnier A; Plantaz D; Bost-Bru C; Eitenschenck L; Durieu I; Floret D; Galambrun C; Chambost H; Michel G; Stephan JL; Hermine O; Blanche S; Blot N; Rubié H; Pouessel G; Drillon-Haus S; Conrad B; Posfay-Barbe KM; Havlicekova Z; Voskresenky-Baricic T; Jadranka K; Arriazu MC; Garcia LA; Sfaihi L; Bordigoni P; Stasia MJ
J Clin Immunol; 2012 Oct; 32(5):942-58. PubMed ID: 22562447
[TBL] [Abstract][Full Text] [Related]
36. Recent topics and advanced therapies in chronic granulomatous disease.
Nunoi H; Nakamura H; Nishimura T; Matsukura M
Hum Cell; 2023 Mar; 36(2):515-527. PubMed ID: 36534309
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
38. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.
El Kares R; Barbouche MR; Elloumi-Zghal H; Bejaoui M; Chemli J; Mellouli F; Tebib N; Abdelmoula MS; Boukthir S; Fitouri Z; M'Rad S; Bouslama K; Touiri H; Abdelhak S; Dellagi MK
J Hum Genet; 2006; 51(10):887-895. PubMed ID: 16937026
[TBL] [Abstract][Full Text] [Related]
39. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.
Dusi S; Nadalini KA; Donini M; Zentilin L; Wientjes FB; Roos D; Giacca M; Rossi F
J Immunol; 1998 Nov; 161(9):4968-74. PubMed ID: 9794433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
